Evidence map›Paper›PMID 21865131›Full record

ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2011

Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention.

María Sereno, Cristina Aguayo, Carmen Guillén Ponce, César Gómez-Raposo, Francisco Zambrana, Miriam Gómez-López, Enrique Casado

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2018
    Article
  7. Article
  8. Article
  9. Advances of Molecular Targeted Therapy in Gastric Cancer.Journal of gastrointestinal cancer · 2016
    Review
  10. Familial Gastric Cancers.The oncologist · 2015
    Review
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

María SerenoMedical Oncology Department, Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain. mariasereno75@mail.com
Cristina Aguayo
Carmen Guillén Ponce
César Gómez-Raposo
Francisco Zambrana
Miriam Gómez-López
Enrique Casado
Hospital Universitario Infanta Sofía · ESInstituto Cajal · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is the major cause of cancer-related deaths worldwide. The majority of them are classified as sporadic, whereas the remaining 10% exhibit familial clustering. Hereditary diffuse gastric cancer (HDGC) syndrome is the most important condition that leads to hereditary gastric cancer. However, other hereditary cancer syndromes, such as hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, Peutz-Jeghers syndrome, Li-Fraumeni syndrome and hereditary breast and ovarian cancer, entail a higher risk compared to the general population for developing this kind of neoplasia. In this review, we describe briefly the most important aspects related to clinical features, molecular biology and strategies for prevention in hereditary gastric associated to different cancer syndromes.

Indexed as

CarcinomaNeoplastic Syndromes, HereditaryStomach NeoplasmsAdenomatous Polyposis ColiGenetic CounselingGenetic Predisposition to DiseaseHumansModels, BiologicalMolecular BiologyPreventive Medicine

Identifiers

PMID21865131
OpenAlexW2087224842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.